WE ARE GOING TO EWMA!

What is L-Mesitran?

In 2002, we were the first company to obtain CE certification and FDA approval for our Medical-Grade Honey: L-Mesitran. Then and now, we aspire to deliver high quality products to ensure fast and efficient wound healing. We are More Than Honey. We research honey and the ways to improve this natural ingredient. As a result, we supplement our Medical Grade Honey with e.g. vitamins to be even more efficacious.

L-Mesitran is producing medical-grade honey products and will present the findings at EWMA 2023

Topics EWMA 2023

This year we have three presentations about Medical-Grade Honey and it’s wound healing capabilities.

#1 Medical-Grade Honey enhances the healing of Caesarean section wounds and does not compromise in the prevention of infections when compared to antibiotics combined with povidone-iodine.

Accepted as E-poster presentation, read the article here.

"MGH is a potent alternative treatment to replace antibiotics and povidone-iodine, while simultaneously promoting healing."
Niels Cremers, PhD
Head of Research

#2 Medical-Grade Honey, an alternative to decrease bacterial load in the wound bed.

Accepted as E-poster presentation

"MGH is a cost-effective, easy-to-use alternative to treat chronic wound infections."
Daniela Chrysostomou
Wound Care Specialist

#3 Use of Medical-Grade Honey in the management of heel pressure ulcers: a case series

Accepted as E-poster presentation

"MGH-based products are clinically and cost-effective for treating hard-to-heal pressure ulcers such as HPU."
Georgios E. Papanikolaou,
MD, PhD
Plastic Surgeon

#1 The use of Medical-Grade Honey promotes faster healing of Caesarean section wounds without compromising infection prevention, as compared to a combination of antibiotics and povidone-iodine.

#2 Medical-Grade Honey, an alternative to decrease bacterial load in the wound bed.

#3 Use of Medical-Grade Honey in the management of heel pressure ulcers: a case series.

Accepted as E-poster presentation, read the article here.

"MGH presents a powerful alternative therapy to antibiotics & povidone-iodine, while also fostering the process of healing."
Niels Cremers, PhD
Head of Research

Accepted as E-poster presentation

"MGH is a cost-effective, easy-to-use alternative treatment for chronic wound infections."
Daniela Chrysostomou
Wound Care Specialist

Accepted as E-poster presentation

"MGH products are clinically & economically efficient for treatment of challenging-to-heal pressure ulcers, such as HPU."
Georgios E. Papanikolaou, MD, PhD
Plastic Surgeon

Presentations during the previous edition of EWMA